HaemoglobinA1c [clinicaltrials_resource:5a845bebb39dad640b8777fd1e5557fd]

HaemoglobinA1c [clinicaltrials_resource:5a845bebb39dad640b8777fd1e5557fd]

Metformin plus placebo-Repgalinide. Double-masked, randomized. Duration: Four months.
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:5a845bebb39dad640b8777fd1e5557fd
Effect of Metformin Versus Repaglinide Treatment in Non-Obese Type 2 Diabetic Patients Uncontrolled by Diet [clinicaltrials:NCT00118950]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

HaemoglobinA1c [clinicaltrials_resource:5a845bebb39dad640b8777fd1e5557fd]

Metformin plus placebo-Repgalinide. Double-masked, randomized. Duration: Four months.
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:5a845bebb39dad640b8777fd1e5557fd
Bio2RDF identifier
5a845bebb39dad640b8777fd1e5557fd
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:5a845bebb39dad640b8777fd1e5557fd
measure [clinicaltrials_vocabulary:measure]
description
Metformin plus placebo-Repgalinide. Double-masked, randomized. Duration: Four months.
identifier
clinicaltrials_resource:5a845bebb39dad640b8777fd1e5557fd
title
HaemoglobinA1c
@en
inDataset
type
label
HaemoglobinA1c [clinicaltrials_resource:5a845bebb39dad640b8777fd1e5557fd]
@en